SCHEMBL2533962

SCHEMBL2533962

COc1cccc2c1-c1ccccc1N(S(=O)(=O)c1ccc(Cl)c(Cl)c1)C2C(C(=O)O)C1c2cccc(OC)c2-c2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BDKRB1 P46663 7/20 0.54
PSEN1 P49768 1/20 0.36
PSEN2 P49810 1/20 0.36
APH1B Q8WW43 1/20 0.36
NCSTN Q92542 1/20 0.36
APH1A Q96BI3 1/20 0.36
PSENEN Q9NZ42 1/20 0.36
LMNA P02545 2/20 0.36
HTT P42858 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
AKR1C3 P42330 1/20 0.35
AKR1C2 P52895 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
EIF4E P06730 1/20 0.35
NR3C1 P04150 1/20 0.35
HSD17B10 Q99714 2/20 0.35
USP2 O75604 1/20 0.35
GLA P06280 1/20 0.35
TSHR P16473 1/20 0.35
MAPK1 P28482 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2531257 0.89 BDKRB1 (0.46) BDKRB1PSEN1PSEN2APH1BNCSTN
SCHEMBL2518199 0.84 BDKRB1 (0.65) BDKRB1PSEN1PSEN2APH1BNCSTN
SCHEMBL2519324 0.81 BDKRB1 (0.67) BDKRB1
SCHEMBL2534947 0.80 BDKRB1 (0.51) BDKRB1PSEN1PSEN2APH1BNCSTN
SCHEMBL2531813 0.79 BDKRB1 (0.49) BDKRB1PSEN1PSEN2APH1BNCSTN
SCHEMBL2528711 0.78 BDKRB1 (0.41) BDKRB1PSEN1PSEN2APH1BNCSTN
SCHEMBL2516427 0.75 BDKRB1 (0.54) BDKRB1PSEN1PSEN2APH1BNCSTN
SCHEMBL2521885 0.73 BDKRB1 (0.55) BDKRB1PSEN1PSEN2APH1BNCSTN
SCHEMBL2518681 0.70 BDKRB1 (1.00) BDKRB1SMN1; SMN2
SCHEMBL2518683 0.70 BDKRB1 (1.00) BDKRB1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8034827-B2 Phenanthridine derivatives as bradykinin antagonists Richter Gegeon Nyrt. (HU) 2011-10-11 US disclosed
US-20090270411-A1 PHENANTHRIDINE DERIVATIVES AS BRADYKININ ANTAGONISTS RICHTER GEDEON NYRT. (HU) 2009-10-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090270411-A1 PHENANTHRIDINE DERIVATIVES AS BRADYKININ ANTAGONISTS BDKRB2, BDKRB1, HRH2 BDKRB1 2/4885PSEN1 950/4885PSEN2 1075/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.